Overview

Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to confirm efficacy and safety of NT 201 (Xeomin®, also known as IncobotulinumtoxinA) after one injection session and to determine the efficacy and safety profile and the duration of treatment effect of NT 201 in long-term treatment with repeated injection sessions.

Phase:

Phase 4

Details

Lead Sponsor:

Merz Pharmaceuticals GmbH

Treatments:

incobotulinumtoxinA